China's CXMT, YMTC, SMIC expanding aggressively — each fab expansion order means incremental ACMR equipment revenue. China WFE 2026 spend est. $40–50B
2026–2027FY26 guide $1.08B–$1.175B confirmed. Q2 shipments of $241M (+54% YoY) should drive revenue recognition acceleration in H2
Aug 5, 2026First PECVD SiCN system shipped (Apr 2026) — opens advanced BEOL/packaging market outside China. Reduces geopolitical concentration risk
H2 2026Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution
Wall Street price targets vs the current price — cross-check our TP levels
Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic
Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.
Use this stop-loss set (-20% / -20%) only when trading the earnings spot — not for the core holding (use the -20.5% / -47.3% set above). If you are holding long-term, follow the core set.
ACMR typically runs 15–25% in 4–6 weeks before earnings as channel checks on China fab capex spending leak positive. Q1 2026 was a strong beat (+34% revenue, EPS $0.34 vs $0.20).
Market cap $7.2B exceeds turbo profile — 2% max. Best risk/reward only if entered on dip near analyst consensus $88. At current $104, risk/reward is moderate at best.
Generated 2026-06-24 · Not financial advice